New scanner aims to sharpen diagnosis of blood vessel disease
NCT ID NCT07628075
First seen Jun 06, 2026 · Last updated Jun 20, 2026 · Updated 2 times
Summary
This study will test a new type of PET/CT scanner (called long-axial field-of-view) to see if it can provide clearer images of inflammation in the blood vessels of people with large vessel vasculitis. Researchers will compare scans from 18 participants (12 with vasculitis and 6 healthy volunteers) to develop a standardized imaging protocol. The goal is to improve diagnosis and monitoring of this condition, potentially reducing the need for treatments with serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LARGE VESSEL VASCULITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Imperial College Healthcare NHS Trust
London, Greater London, W2 1NY, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
King's College London
London, Greater London, SE1 7EH, United Kingdom
Contact
Contact Email: •••••@•••••
-
Royal Free London NHS Foundation Trust
London, Greater London, NW3 2QG, United Kingdom
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
[18F]FDG (a radioactive sugar tracer) and CT contrast dye
What this could lead to
If successful, this could lead to a standardized, more accurate imaging protocol for diagnosing and monitoring large vessel vasculitis, potentially reducing unnecessary treatments.
What could go wrong
This is a very small, early-phase study (18 participants) focused on optimizing imaging, not testing a treatment. The new scanner may not prove significantly better than current methods in practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.